Location History:
- Stockton, CA (US) (2013)
- San Francisco, CA (US) (2014 - 2017)
Company Filing History:
Years Active: 2013-2017
Title: Kenneth Stanley Matthews: Innovator in Antiviral Compounds
Introduction
Kenneth Stanley Matthews is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of antiviral compounds, holding a total of 4 patents. His work has been instrumental in developing processes that aid in the synthesis of antiviral agents.
Latest Patents
Matthews' latest patents focus on the synthesis of antiviral compounds. The disclosures provide processes for the preparation of a compound of formula I, which is useful as an antiviral agent. Additionally, the disclosures include compounds that serve as synthetic intermediates to compounds of formula I. This innovative work showcases his commitment to advancing antiviral research.
Career Highlights
Throughout his career, Kenneth Matthews has worked with prominent companies in the pharmaceutical industry. He has been associated with Gilead Pharmasset LLC and Merck Sharp & Dohme Corporation, where he contributed to various research initiatives. His experience in these organizations has further solidified his reputation as a leading inventor in his field.
Collaborations
Matthews has collaborated with several talented individuals, including Robert William Scott and Justin Philip Vitale. These partnerships have enhanced his research and development efforts, leading to impactful innovations in antiviral compounds.
Conclusion
Kenneth Stanley Matthews is a distinguished inventor whose work in antiviral compounds has made a significant impact in the field. His patents and collaborations reflect his dedication to advancing medical science and improving public health.